Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
10,781,082
-
Number of holders
-
24
-
Total 13F shares, excl. options
-
1,400,629
-
Shares change
-
+53,913
-
Total reported value, excl. options
-
$15,656,000
-
Value change
-
+$604,001
-
Number of buys
-
15
-
Number of sells
-
-5
-
Price
-
$11.18
Significant Holders of Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) as of Q3 2021
24 filings reported holding LTRN - Lantern Pharma Inc. - Common Stock, par value $0.0001 per share as of Q3 2021.
Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) has 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,400,629 shares
of 10,781,082 outstanding shares and own 13% of the company stock.
Largest 10 shareholders include Corriente Advisors, LLC (625,873 shares), VANGUARD GROUP INC (270,820 shares), GWM Advisors LLC (155,859 shares), GEODE CAPITAL MANAGEMENT, LLC (57,043 shares), MORGAN STANLEY (47,927 shares), Redmond Asset Management, LLC (47,442 shares), WOLFF WIESE MAGANA LLC (35,316 shares), Bank of New York Mellon Corp (26,765 shares), RAYMOND JAMES & ASSOCIATES (25,879 shares), and STATE STREET CORP (25,567 shares).
This table shows the top 24 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.